Try our Advanced Search for more refined results

October 18, 2013

BAXTER HEALTHCARE CORPORATION et al v. HQ SPECIALTY PHARMA CORPORATION

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 05, 2017

    HQ's Heart-Drug Generic Would Flout Baxter Deal, Judge Says

    A New Jersey federal judge has blocked HQ Specialty Pharma Corp. from seeking the U.S. Food and Drug Administration's approval for a new generic version of Baxter Healthcare Corp.'s antiarrhythmic drug Brevibloc, ruling the action would violate an earlier settlement resolving patent infringement allegations.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login